# Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients

> **NCT07737977** · — · NOT_YET_RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 200 (estimated)

## Conditions studied

- ALS (Amyotrophic Lateral Sclerosis)

## Interventions

- **OTHER:** peripheral venous blood collection
- **OTHER:** collection of medical data related to patient care

## Key facts

- **NCT ID:** NCT07737977
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2029-02
- **Final completion:** 2029-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07737977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07737977, "Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07737977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*